glutamate signalling in healthy and diseased bone

Clicks: 197
ID: 253379
2012
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Bone relies on multiple extracellular signalling systems to maintain homeostasis of its normal structure and functions. The amino acid glutamate is a fundamental extracellular messenger molecule in many tissues, and is used in bone for both neural and non-neural signalling. This review focuses on the non-neural interactions, and examines the evolutionarily ancient glutamate signalling system in the context of its application to normal bone functioning and discusses recent findings on the role of glutamate signalling as they pertain to maintaining healthy bone structure. The underlying mechanisms of glutamate signalling and the many roles glutamate plays in modulating bone physiology are featured, including those involved in osteoclast and osteoblast differentiation and mature cell functions. Moreover, the relevance of glutamate signalling systems in diseases that affect bone, such as cancer and rheumatoid arthritis, is discussed, and will highlight how the glutamate system may be exploited as a viable therapeutic target. We will identify novel areas of research where knowledge of glutamate communication mechanisms may aid in our understanding of the complex nature of bone homeostasis. By uncovering the contributions of glutamate in maintaining healthy bone, the reader will discover how this complex molecular signalling system may advance our capacity to treat bone pathologies.
Reference Key
cowan2012frontiersglutamate Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Robert W. Cowan;Eric P. Seidlitz;Gurmit eSingh
Journal aip advances
Year 2012
DOI
10.3389/fendo.2012.00089
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.